Susquehanna International Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.8M Sell
378,706
-137,900
-27% -$9.6M ﹤0.01% 2012
2025
Q4
$34.3M Buy
516,606
+336,668
+187% +$21.8M ﹤0.01% 1687
2025
Q3
$12.1M Buy
179,938
+100,280
+126% +$7.94M ﹤0.01% 2794
2025
Q2
$6.95M Sell
79,658
-56,100
-41% -$4.4M ﹤0.01% 3385
2025
Q1
$9.27M Sell
135,758
-276,679
-67% -$22.6M ﹤0.01% 2626
2024
Q4
$32.1M Buy
412,437
+301,902
+273% +$22.4M ﹤0.01% 1464
2024
Q3
$7.41M Sell
110,535
-20,411
-16% -$1.68M ﹤0.01% 3014
2024
Q2
$14.8M Sell
130,946
-79,437
-38% -$10M ﹤0.01% 2043
2024
Q1
$29.2M Buy
210,383
+526
+0.3% +$66.1K 0.01% 1433
2023
Q4
$26M Buy
209,857
+28,510
+16% +$2.91M 0.01% 1534
2023
Q3
$16.9M Buy
181,347
+10,741
+6% +$1.21M ﹤0.01% 1926
2023
Q2
$21.9M Sell
170,606
-138,917
-45% -$16.8M ﹤0.01% 1638
2023
Q1
$36M Sell
309,523
-346,722
-53% -$38.8M 0.01% 1171
2022
Q4
$74.3M Buy
656,245
+567,362
+638% +$62.3M 0.02% 687
2022
Q3
$7.16M Sell
88,883
-123,232
-58% -$10.4M ﹤0.01% 2620
2022
Q2
$15.8M Sell
212,115
-735,301
-78% -$67.1M ﹤0.01% 1666
2022
Q1
$121M Sell
947,416
-64,388
-6% -$7.04M 0.02% 574
2021
Q4
$136M Buy
1,011,804
+865,316
+591% +$124M 0.02% 601
2021
Q3
$20M Sell
146,488
-169,208
-54% -$21.3M ﹤0.01% 1963
2021
Q2
$33.7M Buy
315,696
+25,048
+9% +$2.41M ﹤0.01% 1502
2021
Q1
$26.1M Sell
290,648
-378,548
-57% -$35.5M ﹤0.01% 1591
2020
Q4
$61.9M Buy
669,196
+407,352
+156% +$36.4M 0.01% 892
2020
Q3
$27M Sell
261,844
-386,956
-60% -$40.4M 0.01% 1240
2020
Q2
$65.8M Buy
648,800
+186,020
+40% +$16.6M 0.02% 684
2020
Q1
$31.2M Buy
462,780
+251,576
+119% +$15.7M 0.01% 915
2019
Q4
$11.6M Buy
211,204
+97,640
+86% +$4.63M ﹤0.01% 1935
2019
Q3
$4.24M Sell
113,564
-247,624
-69% -$9.62M ﹤0.01% 2951
2019
Q2
$13.5M Sell
361,188
-80,128
-18% -$2.52M ﹤0.01% 1604
2019
Q1
$13.1M Buy
441,316
+238,652
+118% +$8.39M 0.01% 1511
2018
Q4
$6.07M Buy
202,664
+196,456
+3,165% +$6.23M ﹤0.01% 2072
2018
Q3
$222K Sell
6,208
-104,528
-94% -$3.24M ﹤0.01% 8030
2018
Q2
$2.63M Buy
+110,736
New +$2.35M ﹤0.01% 3590
2018
Q1
Sell
-461,144
Closed -$6.82M 9463
2017
Q4
$6.62M Sell
461,144
-116,192
-20% -$1.51M ﹤0.01% 2220
2017
Q3
$7.06M Buy
577,336
+506,796
+718% +$8.96M ﹤0.01% 2116
2017
Q2
$1.29M Sell
70,540
-94,004
-57% -$1.74M ﹤0.01% 4738
2017
Q1
$3.48M Buy
+164,544
New +$3.21M ﹤0.01% 2810
2016
Q4
Sell
-62,680
Closed -$1.11M 9661
2016
Q3
$1.37M Buy
62,680
+28,152
+82% +$627K ﹤0.01% 4207
2016
Q2
$685K Sell
34,528
-145,728
-81% -$2.48M ﹤0.01% 5566
2016
Q1
$3.06M Sell
180,256
-9,592
-5% -$160K ﹤0.01% 3027
2015
Q4
$3.89M Sell
189,848
-286,784
-60% -$5.97M ﹤0.01% 2876
2015
Q3
$10.2M Buy
476,632
+335,184
+237% +$7.48M ﹤0.01% 1804
2015
Q2
$2.83M Sell
141,448
-104,708
-43% -$1.84M ﹤0.01% 3968
2015
Q1
$3.84M Buy
246,156
+95,500
+63% +$1.44M ﹤0.01% 3134
2014
Q4
$2.07M Buy
150,656
+45,600
+43% +$558K ﹤0.01% 4401
2014
Q3
$1.05M Sell
105,056
-64,280
-38% -$657K ﹤0.01% 5816
2014
Q2
$1.68M Sell
169,336
-296,064
-64% -$2.62M ﹤0.01% 4995
2014
Q1
$4.81M Buy
465,400
+212,784
+84% +$2.2M ﹤0.01% 2945
2013
Q4
$2.24M Buy
252,616
+151,744
+150% +$1.2M ﹤0.01% 4090
2013
Q3
$712K Buy
+100,872
New +$639K ﹤0.01% 5860

Other funds holding DXCM

Susquehanna International Group's DXCM Position: Q1 2026 in Review

Susquehanna International Group reduced its DexCom (DXCM) stake by 27% in Q1 2026, selling an estimated $9.6M and leaving 378,706 shares worth $23.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2012.

Susquehanna International Group first reported a position in DXCM in Q3 2013 and has held it in 49 quarters since. The position peaked at $136M in Q4 2021. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Susquehanna International Group held 378,706 shares of DexCom worth $23.8M as of Q1 2026.
  • Susquehanna International Group sold 137,900 DexCom shares in Q1 2026, an estimated $9.6M.
  • DexCom made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2012 holding.
  • Susquehanna International Group first reported a position in DexCom in Q3 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's DexCom position peaked at $136M in Q4 2021.
  • 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.